Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2014

Apr 14, 2014

65058_rns_2014-04-14_f234bea3-7e31-4c95-a94a-9a1f6bbbe8f4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Name of Entity PRIMARY HEALTH CARE LIMITED

ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Dr Paul Francis Jones

Date of last notice

21 February 2014

Part 1 - Change of director’s relevant interests in securities Part 1 - Change of director’s relevant interests in securities
_Inthe case of a trust, this includes interests inthe trust made available by the responsible _ entity of the trust
Direct or indirect interest As shown
Nature of indirect interest Not applicable
(including registered holder)
Date of change 14 April 2014
No. of securities held prior to change
Dr Paul F Jones Pty Ltd 35,000 unlisted options
over Ordinary Shares
Pannly Pty Ltd ATF Jones 2,065 Ordinary Shares
Family Trust
Class Fully paid ordinary shares
Number acquired 40
Number disposed Not applicable
Value/Consideration $4.697 per share (DRP)
No. of securities held after change
Dr Paul F Jones Pty Ltd 35,000 unlisted options
over Ordinary Shares
Pannly Pty Ltd ATF Jones 2,105 Ordinary Shares
Family Trust
Nature of change
Example: on-market trade, off-market trade, exercise of Dividend Reinvestment Plan
options, issue of securities under dividend reinvestment plan,
participation in buy-back

Part 2 – Change of director’s interests in contracts Not applicable Part 3 – Closed period

Were the interests in the securities or contracts Not applicable detailed above traded during a closed period where prior written clearance was required? If so, was prior written clearance provided to allow Not applicable the trade to proceed during this period? If prior written clearance was provided, on what Not applicable date was this provided?

YD CACHIA Company Secretary Date: 15 April 2014

  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002